NCLT sanctions Dr. Agarwal’s Eye Hospital merger into Dr. Agarwal’s Health Care
As filed · Dr. Agarwal's Health Care Limited has informed the Exchange about the receipt of Sanction from the Hon'ble NCLT, Chennai Bench towards the Scheme of Amalgamation between Dr. Agarwal s Eye Hospital Lim
What happened
FactThe NCLT Chennai Bench sanctioned the amalgamation of Dr. Agarwal’s Eye Hospital Limited with and into Dr. Agarwal’s Health Care Limited. The order was pronounced on September 30, 2026 and uploaded on October 05, 2026; the certified copy is awaited.
Why it matters
CapitSignal interpretationA merger fixes a share-exchange ratio, which permanently sets how much of the combined company existing holders own.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Debt
Revisedfinance cost actually moved from about close to INR24.7 crores in Q1 of last year to about close to INR23.5 crores.
the interest on deferred acquisition payable was about close to INR6.8 crores in corresponding quarter of last year, which dropped down to about INR3.6 crores.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Swap ratio and its valuation basis
- Regulatory and NCLT approvals required
- Appointed date
- We expect to clock 20% plus revenue growth in FY '26, driven by strengthening presence in existing micro-marke (management committed by FY26)
- We also expect the profit after tax numbers to rise by 35% plus. (management committed by FY26)
Evidence
- Dr. Agarwal's Health Care Limited has informed the Exchange about the receipt of Sanction from the Hon'ble NCLT, Chennai Bench towards the Scheme of Amalgamation between Dr. Agarwal s Eye Hospital Limited and Dr. Agarwal s Health Care Limited and their respective shareholders and creditors.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- The sanction advances the merger from approval to implementation, subject to completion of Scheme conditions. The company will subsequently disclose the Effective Date, Record Date and share allotment under the share exchange ratio.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%